TRIS Rating Affirms Company & Senior Debt Ratings and Outlook of “BGH” at “A+/Stable”

General News Tuesday November 12, 2013 13:01 —TRIS News Release

TRIS Rating has affirmed the company and senior debenture ratings of Bangkok Dusit Medical Services PLC (BGH) at “A+” with “stable” outlook. The ratings reflect BGH’s leading market position as the largest private hospital operator in Thailand, the enhanced capacity of its facilities, large franchise network, experienced management team and capable physicians, high quality services, and modern equipment. These strengths are partially offset by the large capital expenditures for BGH’s expansion in the medium term and the competitive environment in the healthcare service industry. Competition is expected to rise from both local healthcare providers and healthcare providers in other ASEAN countries. The “stable” outlook reflects the expectation that BGH will be able to maintain its leading position in both the domestic and regional private hospital markets and to deliver solid operating performance. BGH is expected to expand its hospital network without a material deterioration in its financial profile. Its EBITDA margin (earnings before interest, tax, depreciation and amortization as a percentage of sales) is expected to maintain at around 20% while its debt to capitalization ratio is expected to stay at around 35%-40%.

BGH was established in 1969 to operate Bangkok Hospital, a private hospital. The company is the largest private hospital operator in Thailand with a strong network of hospital brands. At present, BGH owns 31 hospitals, under five well-known local hospital brands, plus one international hospital brand. Sixteen hospitals are operated under the Bangkok Hospital brand, four hospitals under the Samitivej Hospital brand, and one hospital under the BNH Hospital brand. BGH also has two other domestic hospital brands: the Phyathai Hospital Group (PYT) and the Paolo Memorial Hospital Group (Paolo). Two international hospitals are run under the Royal International Hospital brand. At the end of October 2013, BGH had a service capacity of 4,684 inpatient beds, including two hospitals it recently purchased: the 150-bed Samitivej Thonburi Hospital (formerly known as Khrungdhon Hospital) and the 158-bed Bangkok Phitsanulok Hospital. BGH’s customer base covers the mid- to high-end segments in various locations. Twelve of BGH’s hospitals have achieved Joint Commission International (JCI) accreditation.

BGH’s competitive edge is derived from its diversity in terms of services offered, its customer base, and the locations of hospitals. The company has the largest pool of physicians, nurses, and clinical staff in Thailand, as well as the strongest referral network. BGH’s focus on tertiary care helps boost revenue and increase the utilization of medical equipment and laboratories. The company will widen its customer base by expanding more in secondary care hospitals in the medium term. This effort will let BGH reach more middle income patients. Economies of scale, through the pooling lab services and the centralized purchasing of medicines, medical supplies, and key medical equipment, is expected to benefit the company in terms of cost effectiveness. In addition, the implementation of a cash pooling system reduced the short-term loan requirements for each hospital and lowered the financing cost across the group.

Revenue from hospital operations grew at a compound annual growth rate (CAGR) of 16% from 2007 through 2012. For the first six months of 2013, the company reported total revenues from hospital operations of Bt23,555 million, up by 12% from the same period last year. The rise was driven by growth in patient volume across its network hospitals, increase in healthcare inflation, and rise in patient severity. For the first six months of 2013, outpatient visits per day amounted to 21,257 persons, or a rise of 7% year-on-year (y-o-y). The average daily census (the average number of inpatients per day) rose by 11% y-o-y to 2,941 patients. About 55% of patient revenue came from inpatients; the remainder came from outpatients. Self-pay patients contributed about 70% of total revenue.

BGH’s financial strength is underpinned by its strong operating performance, increasing cash flow, and sufficient liquidity. BGH’s financial profile during the past 12 months was near the expectations of TRIS Rating’s base-case. The operating margin has been relatively stable at 22%-22.5% during the last three years. The margin slightly dropped to 21% for the first six months of 2013 due to higher expenses for doctors, clinical staffs, and administrative expenses. In the medium term, the gross margin is expected to be pressured from a rise in doctors and physicians expenses because BGH is preparing its healthcare resources for its new hospitals and for the effects of the upcoming implementation of the ASEAN Economic Community (AEC). However, BGH is expected to achieve economies of scale and have cost-saving from improvements in asset utilization. Funds from operations (FFO) were Bt8,819 million in 2012, climbing from Bt6,772 million in 2011. FFO for the first six months of 2013 held at Bt4,807 million. FFO is expected to continue to grow, reaching Bt10,000-Bt12,000 million in 2014 and 2015, driven by the opening of its new hospitals and strong growth in patient volume across its network hospitals.

BGH’s total debt at the end of June 2013 was Bt23,328 million, up from Bt16,792 million at the end of 2011. Total debt increased because BGH invested in new hospitals and affiliated companies. However, as BGH has large equity base and carefully manages its capital structure, the debt to capitalization ratio was relatively stable at about 34% during 2011 and 2012. The ratio rose to 37.2% at the end of June 2013. BGH is entering a new investment cycle as it plans to expand its network hospitals from 31 hospitals to 50 hospitals during the next two years. The company also has set an investment budget for the non-hospital segment, e.g., lab services and pharmaceuticals. BGH plans to spend Bt10,000-Bt12,000 million in capital expenditures per annum during 2013-2015. Going forward, BGH’s leverage is likely to rise to accommodate its future capital expenditure requirements. However, TRIS Rating expects BGH’s strong operating cash flow and good relationships with financial institutions will provide the company with sufficient financial flexibility to meet its financial requirements when it expands.

Bangkok Dusit Medical Services PLC (BGH)
Company Rating: A+
Issue Ratings:
BGH143A: Bt1,000 million senior debentures due 2014 A+
BGH146A: Bt1,970 million senior debentures due 2014 A+
BGH153A: Bt2,500 million senior debentures due 2015 A+
BGH166A: Bt1,000 million senior debentures due 2016 A+
BGH233A: Bt4,000 million senior debentures due 2023 A+
Rating Outlook: Stable
TRIS Rating Co., Ltd./www.trisrating.com
Contact: santaya@trisrating.com, Tel: 0-2231-3011 ext 500/Silom Complex Building, 24th Floor, 191 Silom Road, Bangkok 10500, Thailand
Copyright  2013, TRIS Rating Co., Ltd.  All rights reserved. Any unauthorized use, disclosure, copying, republication, further transmission, dissemination, redistribution or storing for subsequent use for any purpose, in whole or in part, in any form or manner or by any means whatsoever, by any person, of the credit rating reports or information is prohibited.  The credit rating is not a statement of fact or a recommendation to buy, sell or hold any debt instruments.  It is an expression of opinion regarding credit risks for that instrument or particular company. The opinion expressed in the credit rating does not represent investment or other advice and should therefore not be construed as such. Any rating and information contained in any report written or published by TRIS Rating has been prepared without taking into account any recipient’s particular financial needs, circumstances, knowledge and objectives. Therefore, a recipient should assess the appropriateness of such information before making an investment decision based on this information. Information used for the rating has been obtained by TRIS Rating from the company and other sources believed to be reliable. Therefore, TRIS Rating does not guarantee the accuracy, adequacy, or completeness of any such
information and will accept no liability for any loss or damage arising from any inaccuracy, inadequacy or incompleteness. Also, TRIS Rating is not responsible
for any errors or omissions, the result obtained from, or any actions taken in reliance upon such information. All methodologies used can be found at http://www.trisrating.com/en/rating_information/rating_criteria.html.

เว็บไซต์นี้มีการใช้งานคุกกี้ ศึกษารายละเอียดเพิ่มเติมได้ที่ นโยบายความเป็นส่วนตัว และ ข้อตกลงการใช้บริการ รับทราบ